Quick Heal Tech Standalone December 2021 Net Sales at Rs 79.63 crore, up 11.95% Y-o-Y
NULL24-01-2022
Q3FY22 Quarterly Result Announced for Quick Heal Technologies Ltd.
IT Software Products company Quick Heal Technologies declares Q3FY22 result: Quick Heal Technologies Third Quarter Revenue Grows 14%, Enterprise segment continues to grow in double digits Revenue at Rs 796 mln up 14% EBIDTA at Rs 205 mln up 24% PAT at Rs 143 mln up 6% EPS at Rs 2.45 up 17% Continues to be a debt free company Dr. Kailash Katkar, Managing Director and Chief Executive Officer, Quick Heal Technologies Limited, said, “We delivered a robust third quarter in terms of revenue, subscribers, profitability and cash flow which is a testament to our team’s strong execution. Our continued commitment to secure our customers’ ever-increasing online footprint helped us add 818 thousand new subscribers. The growth in enterprise segment has been promising and we expect the momentum to continue in the coming quarters. In line with our strategy to boost market share, we continue to invest in R&D; and strengthen leadership team that will enable us to launch next-generation solutions in the coming quarters,” he added. Mr. Navin Sharma, Chief Financial Officer, Quick Heal Technologies Limited, said, “We delivered solid results in Q3, as continued strong demand for our cybersecurity products across our diversified global go-to-market channels, coupled with our focus on operational discipline, resulted in 14% Y-o-Y growth in Revenue and 24% Y-o-Y growth in EBITDA. In line with our continued focus on R&D; and innovation, we spent 27% of revenues as R&D; during the quarter. Our balance sheet remains strong with zero debt and cash and cash equivalents of Rs 3,275 mln as on 31st December 2021. We are committed to driving shareholder value by growing profitability across both of our segments and driving solid Unlevered Cash Flow.” Result PDF24-01-2022
Quick Heal Technologies Ltd - 539678 - Results- Financial Statements For The Quarter Ended December 31, 2021
We wish to inform you that the Board of Directors at its meeting held on January 24, 2022 through video conferencing has approved the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2021.24-01-2022
Quick Heal Technologies Ltd - 539678 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Call for Q3FY22 Results21-01-2022
Quick Heal Technologies Ltd - 539678 - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended December 31, 2021
Quick Heal Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2022 ,inter alia, to consider and approve standalone and consolidated financial results of the Company along with the Limited Review Report of Statutory Auditors thereon for the quarter ended December 31, 2021;18-01-2022
Quick Heal Technologies Ltd - 539678 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Quick Heal Technologies Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here18-01-2022
Quick Heal Technologies Ltd - 539678 - Results Of The Postal Ballot And E-Voting
Please find enclosed Voting results pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and Report of Scrutinizer dated January 18, 2022. The resolutions in the postal ballot notice have been deemed to be approved and passed on January 16, 2022 which is the last date of e-voting.18-01-2022
Quick Heal Technologies Ltd - 539678 - Shareholding for the Period Ended December 31, 2021
Quick Heal Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here11-01-2022
Quick Heal Technologies Ltd - 539678 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Kailash KatkarDesignation :- Chief Executive Officer10-01-2022
Quick Heal Technologies Ltd - 539678 - Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform that the Trading Window of the Company shall be closed from January 01, 2022 and shall be opened 48 hours after declaration of Financial Results for the quarter and nine months ended on December 31, 2021.30-12-2021